drugset / Trial / NCT04909918

Impact of Steroids on Inflammatory Response in Covid-19

NCT04909918

Phase 3 Completed 60 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

we designed this study to observe the efficacy and safety of dexamethasone versus methylprednisolone in covid-19 diseased patients upon monitoring the inflammatory response and to compare the outcome when these steroids will be given in covid-19 diseased patients in our ICU.

Timeline

Start
2021-05-28
Primary completion
2021-08-15
Completion
2021-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 8 mg Intravenous
Subject Methylprednisolone Other / unclassified 1 mg/kg Intravenous

Indications